Zimmer Biomet is betting that a portfolio of technologies that support surgeon preferences will help it gain ground in robotics and defend its joint replacement position.
Tariffs were a key topic at OMTEC 2025, with industry leaders stressing the importance of understanding the complexity of the evolving situation to prioritize a response.
Smaller European and Asian companies have shown interest in the U.S. and markets outside of their headquarter region. Citieffe is a prime example of this strategic focus.